Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 7, 2016; 22(33): 7579-7586
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7579
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7579
Table 3 Comparison of autoantibodies between untyped drug-induced liver injury and primary biliary cirrhosis patients n (%)
| ANA | AMA | SMA | AMA-M2 | AMA-M4 | AMA-M9 | |
| DILI (n = 124) | 55 (44.3) | 4 (3.22) | 4 (3.22) | 3 (2.42) | 1 (0.80) | 3 (2.42) |
| PBC (n = 116) | 98 (84.4) | 98 (84.4) | 2 (3.45) | 98 (84.4) | 34 (29.3) | 19 (16.3) |
| χ2 | 41.761 | 161.932 | 0.554 | 165.598 | 39.091 | 14.027 |
| P value | < 0.0001 | < 0.0001 | 0.685 | < 0.0001 | < 0.0001 | < 0.0001 |
- Citation: Yang J, Yu YL, Jin Y, Zhang Y, Zheng CQ. Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis. World J Gastroenterol 2016; 22(33): 7579-7586
- URL: https://www.wjgnet.com/1007-9327/full/v22/i33/7579.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i33.7579